These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 15635596)

  • 21. Primary systemic therapy of breast cancer.
    Sachelarie I; Grossbard ML; Chadha M; Feldman S; Ghesani M; Blum RH
    Oncologist; 2006 Jun; 11(6):574-89. PubMed ID: 16794237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative (neoadjuvant) systemic treatment of breast cancer.
    Kaufmann M; von Minckwitz G; Rody A
    Breast; 2005 Dec; 14(6):576-81. PubMed ID: 16199160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy in the treatment of breast cancer.
    Redden MH; Fuhrman GM
    Surg Clin North Am; 2013 Apr; 93(2):493-9. PubMed ID: 23464698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
    Ardavanis A; Scorilas A; Tryfonopoulos D; Orphanos G; Missitzis I; Karamouzis M; Chrysochoou M; Sotiropoulou A; Arnogiannaki N; Ioannidis G; Pissakas G; Rigatos G
    Oncologist; 2006 Jun; 11(6):563-73. PubMed ID: 16794236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Primary chemotherapy in operable breast carcinoma].
    Bonadonna G; Valagussa P
    Ann Ital Chir; 1999; 70(3):359-69. PubMed ID: 10466239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Options and limits of surgery after pre-operative chemotherapy in breast cancer.
    Thomas A; Ohlinger R; Hauschild M; Mustea A; Blohmer JU; Kümmel S
    Anticancer Res; 2006; 26(2C):1677-82. PubMed ID: 16617561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facilitating breast-conserving surgery and preventing recurrence: aromatase inhibitors in the neoadjuvant and adjuvant settings.
    Mamounas EP
    Ann Surg Oncol; 2008 Mar; 15(3):691-703. PubMed ID: 18196346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer.
    Asoglu O; Muslumanoglu M; Igci A; Ozmen V; Karanlik H; Ayalp K; Bozfakioglu Y; Kecer M; Parlak M
    Acta Chir Belg; 2005 Feb; 105(1):62-8. PubMed ID: 15790205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer.
    Clouth B; Chandrasekharan S; Inwang R; Smith S; Davidson N; Sauven P
    Eur J Surg Oncol; 2007 Oct; 33(8):961-6. PubMed ID: 17215100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary-conserving surgery is facilitated by neoadjuvant chemotherapy of breast cancer.
    Beatty JD; Precht LM; Lowe K; Atwood M
    Am J Surg; 2009 May; 197(5):637-41; discussion 641-2. PubMed ID: 19321159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival.
    Dowsett M; Smith IE; Ebbs SR; Dixon JM; Skene A; Griffith C; Boeddinghaus I; Salter J; Detre S; Hills M; Ashley S; Francis S; Walsh G;
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):951s-8s. PubMed ID: 15701892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant systemic therapy and the surgical management of breast cancer.
    Waljee JF; Newman LA
    Surg Clin North Am; 2007 Apr; 87(2):399-415, ix. PubMed ID: 17498534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Does primary chemotherapy really increase the rate of breast conserving treatments?].
    Hennequin C; Espié M; Misset JL; Maylin C
    Cancer Radiother; 2004 Feb; 8(1):48-53. PubMed ID: 15093201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of neoadjuvant chemotherapy for breast cancer treatment].
    Inaji H; Komoike Y; Motomura K; Kasugai T; Koyama H
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1113-9. PubMed ID: 12145989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Breast-conserving therapy in breast cancer].
    Marcollet A; Doridot V; Nos C
    Rev Prat; 2004 Apr; 54(8):847-53. PubMed ID: 15274458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.
    Oh JL; Dryden MJ; Woodward WA; Yu TK; Tereffe W; Strom EA; Perkins GH; Middleton L; Hunt KK; Giordano SH; Oswald MJ; Domain D; Buchholz TA
    J Clin Oncol; 2006 Nov; 24(31):4971-5. PubMed ID: 17075114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of resection volume on locoregional recurrence of breast cancer after breast-conserving surgery.
    Boehm DU; Lebrecht A; Maltaris T; Schmidt M; Siggelkow W; Fischer S; Kandelhart E; Koelbl H
    Anticancer Res; 2008; 28(2B):1207-11. PubMed ID: 18505057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.
    Mauri D; Pavlidis N; Ioannidis JP
    J Natl Cancer Inst; 2005 Feb; 97(3):188-94. PubMed ID: 15687361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant use of endocrine therapy in breast cancer.
    Macaskill EJ; Dixon JM
    Breast J; 2007; 13(3):243-50. PubMed ID: 17461898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.